You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
9 July 2024
Immunic Appoints Jason Tardio as Chief Operating Officer and President (news with additional features)
28 May 2024
Immunic to Participate in Industry and Scientific Conferences in June
8 May 2024
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
6 May 2024
Immunic to Participate in Investor and Scientific Conferences in May
1 May 2024
Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
30 April 2024
Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in RRMS in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation